Evgenia Efthymiou

National and Kapodistrian University of Athens

Papers

1

Total Citations

15

H-Index

1

About

Evgenia Efthymiou is a leading figure in oncologic urology, with a focused expertise in minimally invasive treatments for renal cell carcinoma. Her research bridges the gap between interventional radiology and surgical oncology, particularly comparing the long-term oncologic outcomes of percutaneous microwave ablation and robot-assisted partial nephrectomy for stage I kidney cancer. In her landmark 2024 propensity-matched cohort study, Efthymiou demonstrated that microwave ablation offers comparable oncologic control to robotic surgery while reducing operative morbidity, a finding that has already garnered 15 citations and is reshaping clinical decision-making for early-stage renal tumors. Her work is distinguished by rigorous long-term follow-up data, providing critical evidence for patients who are poor surgical candidates. By systematically evaluating these two modalities, she has helped establish ablation as a viable first-line alternative to nephron-sparing surgery. Efthymiou’s contributions are particularly impactful for urologists and interventional radiologists seeking to optimize personalized treatment pathways, and her ongoing research continues to refine the role of thermal ablation in kidney cancer management.

Research Focus

Key Achievements

1
H-Index
1
Papers
15
Total Citations
15
Avg Citations/Paper
🏆 Most Cited Paper
Percutaneous Microwave Ablation Versus Robot-Assisted Partial Nephrectomy for Stage I Renal Cell Carcinoma: A Propensity-Matched Cohort Study Focusing Upon Long-Term Follow-Up of Oncologic Outcomes
15 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: National and Kapodistrian University of Athens

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago